Andrew Faughnan | executive |
Bradley Campbell | executive |
Sebastien Martel | executive |
Jeffrey Castelli | executive |
Simon Nicolas Harford | executive |
Ritu Baral | analyst |
Dae Gon Ha | analyst |
Joseph Schwartz | analyst |
Eliana Merle | analyst |
Lee Hung | analyst |
Kristen Kluska | analyst |
Great. Thank you. Didi [ph]. Good morning. Thank you for joining our conference call to discuss Amicus Therapeutics' full year 2023 financial results and corporate highlights.